Biogen’s Q4 revenue falls 6% to $2.4 billion



American biotechnology firm Biogen Inc. disclosed on Tuesday that it booked $2.4 billion in revenue during the closing quarter for fiscal 2023, which marked a 6% drop compared to the corresponding tim…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento